NL-OMON33354已完成不适用
Epigenetic changes associated with ECT treatment - epigenetics in ECT treatment
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •depressive disorder and eligible for ECT treatment
排除标准
- •age < 18 years and age >65 jaar
- •major medical conditions that may interfere with the study procedures: cancer, cerebrovascular disorders, organic psychiatric syndromes, active drug abuse, mental retardation, dementia and other neurodegenerative disorders. Psychopathology will be assesses by a psychiatric interview.
- •Illiteracy
- •any condition which in the opinion of the (co-) investigator might interfere with the evaluation of the study objectives
研究者
相似试验
已完成
不适用
The effect of electroconvulsive therapy (ECT) following propofol and etomidate anaesthesia: a randomised double blind trial.Mental and Behavioural Disorders: Electroconvulsive therapy (ECT)Mental and Behavioural DisordersElectroconvulsive therapy (ECT)ISRCTN86210347Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)
招募中
不适用
THE EFFECT OF ELECTRO CONVULSIVE THERAPY (ECT) ON RECONSOLIDATION OF HUMAN LONG-TERM MEMORYAnxiety disorders10002861DepressionNL-OMON32461Radboud Universiteit Nijmegen60
招募中
不适用
ECT-induced connectivity mechanisms in treatment resistant depressioDepression10027946Major Depressive DisorderNL-OMON52975Radboud Universitair Medisch Centrum100
进行中（未招募）
1 期
Prediction of ECT treatment response and reduction of Cognitive Side-effects using EEG and RivastigmineA depressive disorderEUCTR2020-005633-33-NLniversity Medical Center Groningen100
招募中
不适用
Prediction of ECT treatment response and reduction of Cognitive Side-effects using EEG and RivastigmineDepressionNL-OMON27806MC Groningen (investigator initiated)100